Exane Derivatives’s Dow Inc DOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.24M Buy
43,346
+20,045
+86% +$1.28M 1.29% 15
2022
Q1
$1.48M Buy
23,301
+21,993
+1,681% +$1.33M 0.42% 49
2021
Q4
$74.2K Buy
1,308
+123
+10% +$7.01K 0.02% 461
2021
Q3
$68.2K Sell
1,185
-18,436
-94% -$1.13M 0.02% 586
2021
Q2
$1.23M Buy
+19,621
New +$1.3M 0.28% 82
2019
Q4
Sell
-1
Closed -$48 691
2019
Q3
$48 Hold
1
﹤0.01% 642
2019
Q2
$49 Buy
+1
New +$53 ﹤0.01% 648

Other funds holding DOW

Exane Derivatives's DOW Position: Q2 2022 in Review

Exane Derivatives increased its Dow Inc (DOW) stake by 86% in Q2 2022, buying an estimated $1.28M and bringing the position to 43,346 shares worth $2.24M. The position accounts for 1.29% of the portfolio, ranked #15.

Exane Derivatives first reported a position in DOW in Q2 2019 and has held it in 7 quarters since. 1,536 funds tracked by Wall St. Rank hold DOW as of Q2 2022.

  • Exane Derivatives held 43,346 shares of Dow Inc worth $2.24M as of Q2 2022.
  • Exane Derivatives bought 20,045 Dow Inc shares in Q2 2022, an estimated $1.28M.
  • Dow Inc made up 1.29% of Exane Derivatives's portfolio in Q2 2022, its #15 holding.
  • Exane Derivatives first reported a position in Dow Inc in Q2 2019 and has held it in 7 quarters since.
  • 1,536 funds tracked by Wall St. Rank held Dow Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.